Synthesis and binding of 3H-oxymorphazone to rat brain membranes.
Oxymorphazone is a 14-hydroxydihydromorphinone derivative which contains a C-6 hydrazone group and hence could serve as an irreversible label for opioid receptors. 3H-oxymorphazone was synthesized by the reaction of 3H-oxymorphone with excess hydrazine. A specific radioactivity of 640 GBq/mmol (17,3 Ci/mmol) was achieved. Both the unlabelled compound and the tritiated ligand show high affinity to mu and kappa opiate receptor subtypes in rat brain membranes. Two binding sites were detected by equilibrium binding studies, with apparent Kd values of 0.62 nM and 28 nM. About 20% of the H-oxymorphazone specific binding is irreversible after reaction at 1 nM ligand concentration, and this can be enhanced by a higher concentration of tritiated ligand. No azine formation was detected. Preincubation of the membranes with unlabelled oxymorphazone resulted in an irreversible blockade of the high affinity 3H-naloxone binding sites.
D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D004091:Hydromorphone / Q000031:analogs & derivatives*; D066298:In Vitro Techniques; D007553:Isotope Labeling; D007700:Kinetics; D009270:Naloxone / Q000378:metabolism; D010111:Oxymorphone / Q000031:analogs & derivatives*; D011869:Radioligand Assay; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism*; D014316:Tritium
D011957:Receptors, Opioid; D014316:Tritium; D009270:Naloxone; C034640:oxymorphazone; D010111:Oxymorphone; D004091:Hydromorphone